These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33051696)

  • 1. The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis.
    Liu M; Fan F; Zhang Y; Li J
    Eur J Clin Pharmacol; 2021 Mar; 77(3):349-357. PubMed ID: 33051696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals.
    Luzum JA; Kitzmiller JP; Isackson PJ; Ma C; Medina MW; Dauki AM; Mikulik EB; Ochs-Balcom HM; Vladutiu GD
    Cell Metab; 2015 Apr; 21(4):622-7. PubMed ID: 25863251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis.
    Xiang Q; Zhang XD; Mu GY; Wang Z; Liu ZY; Xie QF; Hu K; Zhang Z; Ma LY; Jiang J; Cui YM
    Eur J Clin Pharmacol; 2021 Apr; 77(4):569-581. PubMed ID: 33150478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.
    Mangravite LM; Engelhardt BE; Medina MW; Smith JD; Brown CD; Chasman DI; Mecham BH; Howie B; Shim H; Naidoo D; Feng Q; Rieder MJ; Chen YD; Rotter JI; Ridker PM; Hopewell JC; Parish S; Armitage J; Collins R; Wilke RA; Nickerson DA; Stephens M; Krauss RM
    Nature; 2013 Oct; 502(7471):377-80. PubMed ID: 23995691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites.
    Bai X; Zhang B; Wang P; Wang GL; Li JL; Wen DS; Long XZ; Sun HS; Liu YB; Huang M; Zhong SL
    Acta Pharmacol Sin; 2019 Apr; 40(4):492-499. PubMed ID: 29950617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does reduced creatine synthesis protect against statin myopathy?
    Ballard KD; Thompson PD
    Cell Metab; 2013 Dec; 18(6):773-4. PubMed ID: 24315367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATM gene variants and statin myopathy risk.
    Carr DF; Alfirevic A; Johnson R; Chinoy H; van Staa T; Pirmohamed M
    Nature; 2014 Sep; 513(7518):E1. PubMed ID: 25230669
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
    Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
    Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.
    Nguyen KA; Li L; Lu D; Yazdanparast A; Wang L; Kreutz RP; Whipple EC; Schleyer TK
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1099-1109. PubMed ID: 29785580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.
    Hou Q; Li S; Li L; Li Y; Sun X; Tian H
    Medicine (Baltimore); 2015 Sep; 94(37):e1268. PubMed ID: 26376374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of statin therapy: any new insights in efficacy or safety?
    Hopewell JC; Reith C; Armitage J
    Curr Opin Lipidol; 2014 Dec; 25(6):438-45. PubMed ID: 25313593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review.
    Canestaro WJ; Austin MA; Thummel KE
    Genet Med; 2014 Nov; 16(11):810-9. PubMed ID: 24810685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients.
    Sai K; Kajinami K; Akao H; Iwadare M; Sato-Ishida R; Kawai Y; Takeda K; Tanimoto T; Yamano T; Akasaka T; Ishida T; Hirata KI; Saku K; Yagi S; Soeki T; Sata M; Ueno M; Miyazaki S; Shiraki A; Oyama JI; Node K; Sugamura K; Ogawa H; Kurose K; Maekawa K; Matsuzawa Y; Imatoh T; Hasegawa R; ; Saito Y
    Drug Metab Pharmacokinet; 2016 Dec; 31(6):467-470. PubMed ID: 27839692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression quantitative trait locus analysis identifies novel genes for statin myopathy.
    Voora D
    Circ Cardiovasc Genet; 2014 Apr; 7(2):220-1. PubMed ID: 24736853
    [No Abstract]   [Full Text] [Related]  

  • 15. GATM locus does not replicate in rhabdomyolysis study.
    Floyd JS; Bis JC; Brody JA; Heckbert SR; Rice K; Psaty BM
    Nature; 2014 Sep; 513(7518):E1-3. PubMed ID: 25230668
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink.
    Carr DF; Francis B; Jorgensen AL; Zhang E; Chinoy H; Heckbert SR; Bis JC; Brody JA; Floyd JS; Psaty BM; Molokhia M; Lapeyre-Mestre M; Conforti A; Alfirevic A; van Staa T; Pirmohamed M
    Clin Pharmacol Ther; 2019 Dec; 106(6):1353-1361. PubMed ID: 31220337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a detection algorithm for statin-induced myopathy using electronic medical records.
    Sai K; Hanatani T; Azuma Y; Segawa K; Tohkin M; Omatsu H; Makimoto H; Hirai M; Saito Y
    J Clin Pharm Ther; 2013 Jun; 38(3):230-5. PubMed ID: 23530940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy.
    Turongkaravee S; Jittikoon J; Lukkunaprasit T; Sangroongruangsri S; Chaikledkaew U; Thakkinstian A
    Pharmacogenomics J; 2021 Jun; 21(3):296-307. PubMed ID: 33608664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and skeletal muscles toxicity: from clinical trials to everyday practice.
    Norata GD; Tibolla G; Catapano AL
    Pharmacol Res; 2014 Oct; 88():107-13. PubMed ID: 24835295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy.
    Stringer HA; Sohi GK; Maguire JA; Côté HC
    J Neurol Sci; 2013 Feb; 325(1-2):142-7. PubMed ID: 23312852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.